Cargando…

Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review

OBJECTIVE: The aim of this review is addressing the mechanisms of asbestos carcinogenesis, including chronic inflammation and autophagy-mediated cell survival, and propose potential innovative therapeutic targets to prevent mesothelioma development or improve drug efficacy by reducing inflammation a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zolondick, Alicia A., Gaudino, Giovanni, Xue, Jiaming, Pass, Harvey I., Carbone, Michele, Yang, Haining
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797751/ https://www.ncbi.nlm.nih.gov/pubmed/35098108 http://dx.doi.org/10.21037/pcm-21-12

Ejemplares similares

How asbestos and other fibers cause mesothelioma
por: Gaudino, Giovanni, et al.
Publicado: (2020)

Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
por: Ostroff, Rachel M., et al.
Publicado: (2012)

HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis
por: Gaudino, Giovanni, et al.
Publicado: (2014)

Onconase Mediated NFKβ Down-Regulation in Malignant Pleural Mesothelioma
por: Goparaju, Chandra M., et al.
Publicado: (2011)

An Overview of Asbestos and Malignant Pleural Mesothelioma: An Iranian Perspective
por: Emami, Habib, et al.
Publicado: (2017)

Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma
por: Bononi, Angela, et al.
Publicado: (2020)

HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
por: Pellegrini, Laura, et al.
Publicado: (2017)

Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos
por: Magnani, C, et al.
Publicado: (2000)

Malignant Pleural and Peritoneal Mesothelioma Consequential to Brief Indirect Asbestos Exposure
por: Singhal, Bharati, et al.
Publicado: (2014)

Asbestos Burden Predicts Survival in Pleural Mesothelioma
por: Christensen, Brock C., et al.
Publicado: (2008)

Evaluation of clonal origin of malignant mesothelioma
por: Comertpay, Sabahattin, et al.
Publicado: (2014)

Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma
por: Farahmand, Pooyeh, et al.
Publicado: (2023)

MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion
por: Ak, Guntulu, et al.
Publicado: (2015)

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
por: Sato, Hiroki, et al.
Publicado: (2018)

Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040
por: Oddone, Enrico, et al.
Publicado: (2021)

Asbestos Exposure in Patients with Malignant Pleural Mesothelioma included in the PRIMATE Study, Lombardy, Italy
por: Spinazzè, Andrea, et al.
Publicado: (2022)

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
por: Szymiczek, Agata, et al.
Publicado: (2017)

Germline BAP1 mutations predispose to malignant mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2011)

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012)

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma
por: Carbone, Michele, et al.
Publicado: (2016)

Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
por: Szymiczek, Agata, et al.
Publicado: (2017)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
por: Moro, Jacopo, et al.
Publicado: (2022)

A Rare Case of Malignant Pleural Mesothelioma in a Young Healthy Male Without Asbestos Exposure
por: Khatib, Sohaib, et al.
Publicado: (2021)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Malignant Mesothelioma after Household Exposure to Asbestos
por: Saba, Raya, et al.
Publicado: (2013)

Malignant Peritoneal Mesothelioma Without Asbestos Exposure
por: Abbas, Hafsa, et al.
Publicado: (2019)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

A narrative review of the health disparities associated with malignant pleural mesothelioma
por: Freudenberger, Devon C., et al.
Publicado: (2021)

Serum diagnostic markers for malignant pleural mesothelioma: a narrative review
por: Wang, Jing-Jing, et al.
Publicado: (2022)

CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
por: Kettunen, Eeva, et al.
Publicado: (2019)

The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
por: Oguh-Olayinka, Lily, et al.
Publicado: (2019)

The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
por: Zauderer, Marjorie G.
Publicado: (2021)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022)

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden
por: Järvholm, Bengt, et al.
Publicado: (2015)

Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use
por: Oddone, Enrico, et al.
Publicado: (2020)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cpp23oh091ionha2mhbdhh7k36